|Articles|October 23, 2019
FDA Method for Determination of NDMA in Ranitidine
Author(s)VWR International Ltd
FDA recently posted an LC–HRMS method using the novel ACE3 C18-AR column, which can be used by regulators to detect “probable human carcinogen” NDMA in ranitidine.
Trending on LCGC International
1
Py-GC/MS Detects Microplastics in Pediatric Asthma Patients
2
Industry Roundup: Shimadzu Unveils New High-End UHPLC System Aimed at Reducing Laboratory Downtime
3
LC-MS/MS Compares Hair Hormone Sampling Methods
4
Industry Roundup: Gerstel Showcased New Twister Phases and Automated Liner Exchange Technology at EPRW 2026 in Rotterdam
5